[1]
“ Prodrugs available on the Brazilian pharmaceutical market and their corresponding bioactivation pathways ”, Braz. J. Pharm. Sci., vol. 46, no. 3, pp. 393–420, Sep. 2010, doi: 10.1590/S1984-82502010000300003.